Unregistered Sales of Equity Securities and Use of Proceeds
−Removed: Issuer purchases of equity securities for the three months ended March 31, 2025 were as follows:
+Added: Issuer purchases of equity securities for the three months ended June 30, 2025 were as follows:
ISSUER PURCHASES OF EQUITY SECURITIES
9 unchanged sentences
Under the Plans or Programs (1)
−Removed: January 1 - January 31 2,424,000 $98.65 2,424,000 $12,162
−Removed: February 1 - February 28 4,182,640 $88.23 4,182,640 $11,793
−Removed: March 1 - March 31 6,002,753 $92.61 6,002,753 $11,237
+Added: April 1 - April 30
+Added: 5,233,310 $80.96 5,233,310 $10,813
+Added: May 1 - May 31
+Added: 6,028,900 $78.29 6,028,900 $10,341
+Added: June 1 - June 30
+Added: 5,623,624 $79.14 5,623,624 $9,896
Total 16,885,834 $79.40 16,885,834
−Removed: (1) Shares purchased during the period were made as part of a plan approved by the Board of Directors in October 2018 to purchase up to $10 billion of Merck’s common stock for its treasury.
−Removed: In January 2025, the Board of Directors approved a plan to purchase up to an additional $10 billion of Merck’s common stock for its treasury.
+Added: (1) Shares purchased during the period were made as part of a plans approved by the Board of Directors in both October 2018 and January 2025, each to purchase up to $10 billion of Merck’s common stock for its treasury.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.